Day One Biopharmaceuticals, Inc. (DAWN)

Last Three Months

16-Feb-24 -- 15-May-24

Time Period:

Three Months
|
Year

($1.26M) Net Amount

Buy:	0	--
Sell:	($1.26M)	$15.24 - $16.37

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

2

(1)

12

0

0

+1

0

+2

0

+3

Two Year Chart

16-May-22 -- 15-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
03-May-24 6:48 PM View:	03-May-24 Sale (Planned) ($163.42K)	Bender Jeremy Chief Executive Officer Director		Day One Biopharmaceuticals, Inc. - DAWN	(5%) 1.77M to 1.69M	0	0	--	--	Show Txns Hide Txns

03-May-24 6:44 PM View:	03-May-24 Sale (Planned) ($144.21K)	York Charles N II COO, CFO and Secretary		Day One Biopharmaceuticals, Inc. - DAWN	(23%) 280.42K to 217.29K	0	0	--	--	Show Txns Hide Txns

20-Feb-24 6:48 PM View:	16-Feb-24 Option Sale ($49.43K)	Dubow Adam General Counsel		Day One Biopharmaceuticals, Inc. - DAWN	(16%) 19.83K to 16.59K	0	0	--	--	Show Txns Hide Txns

Yesterday 6:13 PM View:	10-May-24 Market Sale (Planned) ($163.74K)	Blackman Samuel C. HEAD OF R&D		Day One Biopharmaceuticals, Inc. - DAWN	(4%) 2.25M to 2.16M	0	($1.26M) (4%)	--	$15.24 - $16.37	Show Txns Hide Txns